About Modifi Biosciences
Modifi Biosciences is a private company based in New Haven, Connecticut, incorporated in 2021 in Delaware. It has reported $11,469,526 raised in two offerings on Form D since April 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2024 | Aug 29, 2024 | $995,503of $1.0M target | 39 | $25,526 | Debt, Options, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Apr 8, 2022 | Apr 19, 2022amended Aug 3, 2023 | $10,474,023of $11.4M target | 40 | $261K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $11,469,526 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Modifi Biosciences's Form D filed Aug 29, 2024.
KB
Kat Kayser-Bricker
Director
KR
Kevin Rakin
President and director
LB
Lucas de Breed
Director
RB
Ranjit Bindra
Director